STAT

Coronavirus testing is starting to get better — but it has a long way to go

Coronavirus testing is starting to get better — but it has a long way to go, @matthewherper writes.
Source: SEBASTIEN BOZON/AFP/Getty Images

Friday morning a ray of light cracked through the ominous cloud of the pandemic caused by the novel coronavirus: The Swiss health care giant Roche introduced a new test for the virus that could be run more efficiently and with less manpower than existing diagnostics, potentially doubling the capacity in the U.S. to detect the virus.

But the news only emphasizes the degree to which one of the world’s great technological powers, the leading country in generating new biotechnologies and medical

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks